Younger patients with glioblastomas have a significantly better prognosis t
han do older patients. To determine whether patient age might be related to
proliferation of glioblastoma cells, glioblastomas from patients of differ
ent ages were stained with the Molecular Immunology Borstel number 1 antibo
dy to detect proliferating cells. Younger patient age was a significant pre
dictor of a low Molecular Immunology Borstel number 1 proliferation index (
p = 0.0001). This previously unreported association favors an intrinsic dif
ference in the type of glioblastomas that afflict younger patients.